Li-S batteries are considered to be the most promising next-generation advanced energy-storage systems. However, the sluggish reaction kinetics and the "shuttle effect" of lithium polysulfides (LiPSs) severely limit their battery performances. To overcome the complex and multiphase sulfur redox chemistry of LiPSs, in this study, we propose a new type of cobalt-based double catalytic sites (DCSs) codoped mesoporous carbon to immobilize and reversibly catalyze the LiPS intermediates in the cycling process, thus eliminating the shuttle effect and improving the charge-discharge kinetics. The theoretical calculation shows that the well-designed DCS configuration endows LiPSs with both strong and weak binding capabilities, which will facilitate the synergistic and reversible catalytic conversion. Furthermore, the experimental results also confirm that the DCS structure shows significantly enhanced catalytic kinetics than the single catalytic sites. The Li-S battery equipped with the DCS structure displays an extremely high discharge capacity of 918 mA h g at a current density of 0.2 C and can reach a capacity of 867 mA h g after 200 cycles with an ultralow capacity attenuation rate of 0.028% for each cycle. This study opens new avenues to address the catalytic requirements both in discharging and charging processes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.1c17971 | DOI Listing |
Alzheimers Dement
December 2024
Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria.
Background: We identified small molecule tricyclic pyrone compound CP2 as a mild mitochondrial complex I (MCI) inhibitor that induces neuroprotection in multiple mouse models of AD. One of the major concerns while targeting mitochondria is the production of reactive oxygen species (ROS). CP2 consists of two diastereoisomers, D1 and D2, with distinct activity and toxicity profiles.
View Article and Find Full Text PDFBackground: Neurological disorders are at epidemic levels in the world today. Various proteins are being targeted for the development of novel molecular therapeutics; however, no small-molecule inhibitors have been discovered. Recent studies suggest that there are few molecules in clinical trials for various secretase (α, β, and γ), caspase, and calpain inhibitors.
View Article and Find Full Text PDFCurr Cancer Drug Targets
January 2025
Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, 37130-001, MG, Brazil.
Histone Deacetylase 6 (HDAC6) is an intriguing therapeutic target in cancer re-search, distinguished as the only HDAC family member predominantly located in the cyto-plasm. HDAC6 features two catalytic domains and a unique ubiquitin-binding domain, which sets it apart from other HDACs. Beyond its role in histone deacetylation, HDAC6 targets vari-ous nonhistone substrates, such as α-tubulin, cortactin, Heat Shock Protein 90 (HSP90), and Heat Shock Factor 1 (HSF1).
View Article and Find Full Text PDFAdv Mater
January 2025
School of Chemistry and Chemical Engineering, Ministry of Education Key Laboratory of Special Functional Aggregated Materials, Shandong Key Laboratory of Advanced Organosilicon Materials and Technologies, Shandong University, Jinan, 250100, China.
SnO₂ is a widely used electron transport layer (ETL) material in perovskite solar cells (PSCs), and its design and optimization are essential for achieving efficient and stable PSCs. In this study, the in situ formation of a chain entanglement gel polymer electrolyte is reported in an aqueous phase, integrated with SnO₂ as the ETL. Based on the self-polymerization of 3-[[2-(methacryloyloxy)ethyl]dimethylammonium]propane-1-sulfonic acid (DAES) in an aqueous environment, combining the catalytic effect of LiCl (as a Lewis acid) with the salting-out effect, and the introduction of polyvinylpyrrolidone (PVP) as the other polymer chain, a chain entanglement gelled SnO (G-SnO) structure is successfully constructed with a wide range of functions.
View Article and Find Full Text PDFNat Commun
January 2025
Life Sciences Institute, Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
The heterodimeric Rab3GAP complex is a guanine nucleotide exchange factor (GEF) for the Rab18 GTPase that regulates lipid droplet metabolism, ER-to-Golgi trafficking, secretion, and autophagy. Why both subunits of Rab3GAP are required for Rab18 GEF activity and the molecular basis of how Rab3GAP engages and activates its cognate substrate are unknown. Here we show that human Rab3GAP is conformationally flexible and potentially autoinhibited by the C-terminal domain of its Rab3GAP2 subunit.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!